← Back to All Bills

HB1321 Relative to the regulation of the provision of elective intravenous therapy.

Other Dead Auto-scored

Relative to the regulation of the provision of elective intravenous therapy.

Impact Score — How Does This Bill Affect You?

5

Overall Impact Score

Concerning

Scale: 1 (harmful) to 10 (beneficial)

5
💰

Your Wallet

No direct financial impact; regulations could have added costs for providers that might be passed to consumers.

6
🏘️

Your Community

Regulation would have improved safety standards for elective IV services, protecting consumers from unqualified providers.

5
⚖️

Your Freedom

Balances consumer access to elective wellness services against safety oversight.

Status

Inexpedient to Legislate: Motion Adopted Voice Vote 03/05/2026 House Journal 6 P. 19

Sponsor

Alice Wade (D)

The Short Version

Would regulate elective IV therapy services (vitamin drips, hydration therapy, etc.) that have become popular wellness offerings. The bill was killed via Inexpedient to Legislate, meaning the legislature chose not to add new regulations to this growing industry.

Who's Behind This Bill?

Who Benefits

  • Consumers of elective IV therapy (if safety standards improved)
  • Licensed medical professionals

Who Pays the Price

  • IV therapy businesses facing new compliance requirements

Bill statuses as of May 2026. Check LegiScan or NH General Court for the latest.

This bill was auto-scored using AI analysis of the bill text and legislative data. Scores may be refined as we review more bills.